DK0567576T3 - Behandling af neoplastiske sygdomme med interleukin-10 - Google Patents

Behandling af neoplastiske sygdomme med interleukin-10

Info

Publication number
DK0567576T3
DK0567576T3 DK92904687.8T DK92904687T DK0567576T3 DK 0567576 T3 DK0567576 T3 DK 0567576T3 DK 92904687 T DK92904687 T DK 92904687T DK 0567576 T3 DK0567576 T3 DK 0567576T3
Authority
DK
Denmark
Prior art keywords
interleukin
treatment
neoplastic diseases
neoplastic
diseases
Prior art date
Application number
DK92904687.8T
Other languages
Danish (da)
English (en)
Inventor
Kevin W Moore
Paulo J M Vieira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0567576T3 publication Critical patent/DK0567576T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK92904687.8T 1991-01-16 1992-01-15 Behandling af neoplastiske sygdomme med interleukin-10 DK0567576T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64134791A 1991-01-16 1991-01-16

Publications (1)

Publication Number Publication Date
DK0567576T3 true DK0567576T3 (da) 1995-06-12

Family

ID=24571976

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92904687.8T DK0567576T3 (da) 1991-01-16 1992-01-15 Behandling af neoplastiske sygdomme med interleukin-10

Country Status (18)

Country Link
EP (1) EP0567576B1 (de)
JP (1) JP3260368B2 (de)
KR (1) KR100207766B1 (de)
AT (1) ATE116550T1 (de)
AU (1) AU652030B2 (de)
CA (1) CA2100553A1 (de)
CZ (1) CZ282523B6 (de)
DE (1) DE69201128T2 (de)
DK (1) DK0567576T3 (de)
ES (1) ES2068705T3 (de)
FI (1) FI933193A (de)
GR (1) GR3015510T3 (de)
HK (1) HK192196A (de)
HU (1) HU218598B (de)
NO (1) NO310444B1 (de)
OA (1) OA09908A (de)
SK (1) SK279556B6 (de)
WO (1) WO1992012725A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106823A (en) * 1991-01-16 2000-08-22 Schering Corporation Treatment of neoplastic disease with interleukin-10
DE4122402A1 (de) * 1991-07-04 1993-01-07 Schering Ag Verwendung von interleukin 10 zur herstellung von arzneimitteln mit tumorhemmender wirksamkeit
DK0671933T3 (da) * 1992-08-20 1998-09-23 Schering Corp Hidtil ukendte anvendelser af IL-10
US5601815A (en) * 1992-08-21 1997-02-11 Schering Corp IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells
TW381026B (en) * 1993-01-13 2000-02-01 Schering Corp Method of extracorporally activating cytolytic activity of peripheral blood mononuclear cells and pharmaceutical composition comprising the activated peripheral blood mononuclear cells
SK91696A3 (en) * 1994-01-20 1997-04-09 Schering Plough Corp Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
EP1621206A1 (de) 1994-12-12 2006-02-01 Beth Israel Deaconess Medical Center, Inc. Chimäre Zytokine und ihre Verwendung
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
US5770190A (en) * 1995-07-14 1998-06-23 Schering Corporation Method of treatment of acute leukemia with inteleukin-10
AU5827000A (en) * 1999-07-16 2001-02-05 Maria Teresa Bejarano Viral il-10 uses
ES2367891T3 (es) 2000-09-29 2011-11-10 Schering Corporation Interleucina-10 pegilada.
BRPI0719446A2 (pt) 2006-09-28 2013-12-10 Schering Corp Uso de il-10 peguilada para tratar câncer
EP3348281B1 (de) 2008-12-17 2023-07-05 Merck Sharp & Dohme Corp. Herstellung von mono- und di-peg il-10 und verwendungszwecke
JP2016519108A (ja) 2013-04-18 2016-06-30 アルモ・バイオサイエンシーズ・インコーポレイテッド インターロイキン−１０を疾病及び疾患の治療に用いる方法
WO2014204816A2 (en) 2013-06-17 2014-12-24 Armo Biosciences, Inc. Method for assessing protein identity and stability
US10010588B2 (en) 2013-08-30 2018-07-03 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating hyperlipidemia
KR20160079114A (ko) 2013-11-11 2016-07-05 아르모 바이오사이언시스 인코포레이티드 질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
JP2017536098A (ja) 2014-10-14 2017-12-07 アルモ・バイオサイエンシーズ・インコーポレイテッド インターロイキン−１５組成物及びその使用
WO2016064817A1 (en) 2014-10-22 2016-04-28 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
AU2016268403A1 (en) 2015-05-28 2017-12-07 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
JP7053453B2 (ja) 2015-08-25 2022-04-12 アルモ・バイオサイエンシーズ・インコーポレイテッド 疾患及び障害を治療するためのインターロイキン１０の使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
KR960015199B1 (ko) * 1989-12-20 1996-11-01 쉐링 코포레이션 인터페론-γ의 억제제로서의 BCRF1 단백질

Also Published As

Publication number Publication date
JP3260368B2 (ja) 2002-02-25
OA09908A (en) 1994-09-15
KR100207766B1 (ko) 1999-07-15
FI933193A0 (fi) 1993-07-14
CA2100553A1 (en) 1992-07-17
NO310444B1 (no) 2001-07-09
AU652030B2 (en) 1994-08-11
SK279556B6 (sk) 1998-12-02
CZ141293A3 (en) 1994-01-19
HUT69962A (en) 1995-09-28
GR3015510T3 (en) 1995-06-30
EP0567576B1 (de) 1995-01-04
DE69201128T2 (de) 1995-05-24
FI933193A (fi) 1993-07-14
NO932570L (no) 1993-07-15
DE69201128D1 (de) 1995-02-16
HK192196A (en) 1996-10-25
EP0567576A1 (de) 1993-11-03
ATE116550T1 (de) 1995-01-15
JPH06504785A (ja) 1994-06-02
NO932570D0 (no) 1993-07-15
HU218598B (hu) 2000-10-28
ES2068705T3 (es) 1995-04-16
WO1992012725A1 (en) 1992-08-06
AU1261792A (en) 1992-08-27
CZ282523B6 (cs) 1997-07-16
SK74793A3 (en) 1995-03-08
HU9302066D0 (en) 1993-11-29

Similar Documents

Publication Publication Date Title
DK0567576T3 (da) Behandling af neoplastiske sygdomme med interleukin-10
ATE69376T1 (de) Haarwuchsmittel.
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
DK0637238T3 (da) Behandling af makuløs degenerering
KR930702026A (ko) 자기항원의 경구 투여에 의한 자기면역 질병의 치료
BG96892A (bg) Метод и устройство за разпределяне на медикаменти съответствуващи на предписаното лечение на даден пациент
ATE124260T1 (de) Verwendung von melatonin zur behandlung des prämenstruellen syndroms.
ATE125704T1 (de) Behandlung neurodegenerativer erkrankungen.
HU891056D0 (en) Process for treating the diseases of the gullet and the stomach-intestine system
DK472688A (da) Anvendelse af bezafibrat til behandling af diabetes
IT1095103B (it) Apparecchio medicale per la cura della tromeosi venale profonda
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
DK0588873T3 (da) Behandling af levercancer
ES2117008T3 (es) Metodo de tratamiento con amperozida de la esquizofrenia resistente a la terapia.
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
SE8306384L (sv) Farmaceutisk komposition
SE9000658D0 (sv) Mittel zur behandlung der schlaf-apnoe
EP0267402A3 (en) Use of follicle regulatory protein for the production of a therapeutic agent for the treatment of neoplasm of gonadal origin
PT1304107E (pt) Utilizacao de derivados de oxazolidininas para o tratamento da psoriase
IL68896A0 (en) Medicine for treatment of neoplastic diseases
PL283664A1 (en) Therapeutical set for treating limb bone fractures by traction
NO934444D0 (no) Lyskilde for PDT-behandling av hudlidelser
IT1228977B (it) Apparecchio fisioterapico per la cura della sterilita' femminile accertata e per la dilatazione indolore del canale cervicale.
BR8904799A (pt) Aparelho de fototerapia para o tratamento de ictericia do recem nascido
IT1240779B (it) Impiego di l-carnitina nel trattamento delle miopatie funzionali laringee.